Cited by 49Treatment of Major DepressionSchizophrenia research and treatmentAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Comparative study of cognitive impairment between medicated and medication-free patients with remitted major depression: Class-specific influence by tricyclic antidepressants and newer antidepressants

Nagane, Akiko, Baba, Hajime, Nakano, Yoshiyuki, Maeshima, Hitoshi, Hukatsu, Mana, Ozawa, Kazuhiro, Suzuki, Toshihito, Arai, Heii·2014·Psychiatry Research

Abstract

Patients with major depressive disorder (MDD) are known to present with cognitive deficits; however, the presence of these deficits in the remitted state have been inconsistent. One of the most important factors potentially contributing to inconsistencies between studies may be the influence of medications. To explore the influence of antidepressants on cognitive performance in remitted MDD, we evaluated memory and executive functions using Wechsler Memory Scale-Revised and Stroop Color and Word Test, and compared performance among 50 medicated (29 treated with tricyclic antidepressants [TCA], 21 treated with selective serotonin reuptake inhibitors or serotonin noradrenalin reuptake inhibitors) and 19 medication-free MDD patients and 31 controls. The results showed that all 3 MDD groups had significantly lower performance for verbal memory compared with controls. Both medicated groups showed significantly lower performance for visual memory compared with controls; however, the medication-free group did not differ from controls. For the executive function, only the TCA group showed a significantly lower performance compared with controls. These results suggest that cognitive impairment remained even in remitted patients with MDD, however, part of this impairment may be influenced by class-specific antidepressant side effects.

Integrity signals

Registry

Crossref · 10.1016/j.psychres.2014.04.013

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Regarding executive function, only subjects in the tricyclic antidepressant group showed worse performance than the controls.

    “Regarding executive function, only subjects in the TCA group showed worse performance than the controls.”
  • Class-specific side effects may account, at least in part, for the long-lasting cognitive deficits observed in subjects with major depressive disorder in remission.

    “Accordingly, another cross-sectional study that investigated the effects of different antidepressants on cognitive performance suggested that class-specific side effects may account, at least in part, for the long-lasting cognitive deficits observed in subjects with MDD in remission [81].”
  • Individuals from both antidepressant groups, but not from the medication-free group, showed poorer performance in visual memory with respect to healthy controls.

    “Individuals from both antidepressant groups, but not from the medication-free group, showed poorer performance in visual memory with respect to healthy controls.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nagane, A., Baba, H., Nakano, Y., Maeshima, H., Hukatsu, M., Ozawa, K., Suzuki, T., & Arai, H.
Affiliations
Juntendo University (JP)
Corresponding author
Baba, Hajime
Venue
Psychiatry Research
Publisher
Elsevier BV
Published
2014-08
Volume
218
Issue
1-2
Pages
101-105
ISSN
0165-1781 (ISSN-L)
OpenAlex
W2033708300
Cited by
49
References
21
Citations by year
2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 7 · 2016: 9 · 2015: 4 · 2014: 3
FWCI
5.59
Type
journal article
Language
en
Open access
closed
Locations
  • Psychiatry Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Research Support Foundation of the Juntendo Institute of Mental Health
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, remitted depression, cognitive impairment, antidepressants, tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, verbal memory, visual memory, executive function, Stroop task, adverse drug reactions
MeSH terms
Adult, Aged, Antidepressive Agents, Antidepressive Agents, Tricyclic, Cognition, Cognition Disorders, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Male, Memory, Middle Aged, Neuropsychological Tests, Selective Serotonin Reuptake Inhibitors, Executive Function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review